Tech Company Financing Transactions
Apton Biosystems Funding Round
Apton Biosystems, based in Pleasanton, secured $24 million from Kern Partners, Casdin Capital and Khosla Ventures.
Transaction Overview
Company Name
Announced On
7/1/2021
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to continue developing its Super-Res sequencing and single-molecule proteomics detection systems.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
6670 Owens Dr.
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Overview
Apton Biosystems is a Pleasanton, California-based developer of Super-Res(TM) sequencing and single molecule detection systems for large-scale clinical applications such as early cancer detection and population sequencing. Apton has re-imagined the optical systems for sequencing using super-resolution to evaluate molecules spaced closer than a wave-length of light.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Hanna
Browse more venture capital transactions:
Prev: 7/1/2021: Sagetech Avionics venture capital transaction
Next: 7/1/2021: Entera venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs